Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antenatal dexamethasone for imminent late preterm birth in resource-limited settings
ACTRN12617001494325Phase 3Recruiting
- Sponsor
- World Health Organization
- Start
- Dec 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial in preterm birth comparing Dexamethasone with Placebo (2 arms). Primary endpoints: Any baby death, Severe respiratory distress of neonate and 1 more. Started Dec 2017; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
preterm birth
Beyond the preview
Go deeper on ACTRN12617001494325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001494325.